(-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2497-2503

  Sukhthankar, Mugdha ^a,c   Alberti, Saverio ^b   Baek, Seung Joon ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF CHIETI   (Italy)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cycloheximide; EGCG; HCT 116; mRNA stability; SW480; TROP 2

Indexed keywords

EPIGALLOCATECHIN GALLATE; MESSENGER RNA; TROP2 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HCT116; COLORECTAL CANCER; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TEA; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; ANTIGENS, NEOPLASM; ANTIOXIDANTS; CATECHIN; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HCT116 CELLS; HT29 CELLS; HUMANS; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER;

EID: 77955800063     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Alberti S, Miotti S, Stella M, Klein CE, Fornaro M, Mernard S, and Colnaghi MI: Biochemical characterization of TROP2, a cell surface molecule expressed by human carcinomas: Formal proof that the monoclonal antibodies T16 and MOv-16 recognize TROP2. Hybridoma 11: 539-545, 1992.
2. Frodin JE, Lefvert AK and Mellstedt H: Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules. Cancer Res 50: 4866-4871, 1990.
3. Ripani E, Sacchetti A, Corda D and Alberti S: Human TROP2 is a tumor-associated calcium signal transducer. Int J Cancer 76: 671-676, 1998. (Pubitemid 28243939)
4. Dixon CJ, Bowler WB, Walsh CA and Gallagher JA: Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potencies. Br J Pharmacol 120: 777-780, 1997.
5. Tsien RW and Tsien RY: Calcium channels, stores, and oscillations. Annu Rev Cell Biol 6: 715-760, 1990.
6. Basu A, Goldenberg DM and Stein R: The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303. Int J Cancer 62: 472-479, 1995.
7. El Sewedy T, Fornaro M and Alberti S: Cloning of the murine TROP2 gene: Conservation of a PIP2-binding sequence in the cytoplasmic domain of Trop-2. Int J Cancer 75: 324-330, 1998. (Pubitemid 28100077)
8. Lu J, Izvolsky KI, Qian J and Cardoso WV: Identification of FGFlO targets in the embryonic lung epithelium during bud morphogenesis. J Biol Chem 280: 4834-4841, 2005. (Pubitemid 40288656)
9. Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, Matsubara H, Nomura F, Takiguchi M and Hiwasa T: Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 112: 1029-1035, 2004. (Pubitemid 39507010)
10. Guerra E, Trerotola M, Dell' Arciprete R, Bonasera V, Palombo B, El-Sewedy T, Ciccimarra T, Crescenzi C, Lorenzini F, Rossi C, Vacca G, Lattanzio R, Piantelli M and Alberti S: A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 68: 8113-8121, 2008.
11. Wang J, Day R, Dong Y, Weintraub SJ and Michel L: Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther 7: 280-285, 2008. (Pubitemid 351302522)
12. Hara Y, Fujino M, Takeuchi M and Li X-K: Green-tea polyphenol (-)-epigallocatechin-3-gallate provides resistance to apoptosis in isolated islets. J Hepatobiliary Pancreat Surg 14: 493-497, 2007. (Pubitemid 47517219)
13. Sukhthankar M, Yamaguchi K, Lee S-H, McEntee MF, Eling TE, Hara Y and Baek SJ: A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology 134: 1972-1980, 2008.
14. Sukhthankar M, Choi CK, English A, Kim JS and Baek SJ: A potential proliferative gene, NUDT6, is down-regulated by green tea catechins at the posttranscriptional level. J Nutr Biochem 21: 98-106, 2010.
15. Cho KN, Sukhthankar M, Lee SH, Yoon JH, and Baek SJ: Green tea catechin (-)-epicatechin gallate induces tumour suppressor protein ATF3 via EGR-1 activation. Eur J Cancer 43: 2404-2412, 2007. (Pubitemid 47625970)
16. Fang Y, Lu Z, Wang G, Pan ZZ, Zhou MF, Yun JP, Zhang MF, and Wan DS: Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer: Int J Colorectal Dis 24: 875-884, 2009.
17. Malthiery Y, and Lissitzky S: Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem 165: 491-498, 1987. (Pubitemid 17090832)
18. Kiefer MC, Masiarz FR, Bauer DM, and Zapf J: Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum. J Biol Chem 266: 9043-9049, 1991. (Pubitemid 21906616)
19. Singh PN, and Fraser GE: Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol 148: 761-774, 1998. (Pubitemid 28485286)
20. Block G, Patterson B, and Subar A: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18: 1-29, 1992.
21. Calixto JB: Efficacy: Safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 33: 179-189, 2000.
22. Nakazato T, Ito K, Ikeda Y, and Kizaki M: Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin Cancer Res 11: 6040-6049, 2005. (Pubitemid 41170336)
23. Lim YC, Lee SH, Song MH, Yamaguchi K, Yoon JH, Choi EC, and Baek SJ: Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells. Eur J Cancer 42: 3260-3266, 2006. (Pubitemid 44854515)
24. Hong J, Smith TJ, Ho C-T, August DA and Yang CS: Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol 62: 1175-1183, 2001. (Pubitemid 33055621)
25. Chung JY, Huang C, Meng X, Dong Z and Yang CS: Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: Structure-Activity Relationship and Mechanisms Involved. Cancer Res 59: 4610-4617, 1999. (Pubitemid 29428966)
26. Hofmann CS and Sonenshein GE: Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J 17: 702-704, 2003.
27. Hao X, Sun Y, Yang CS, Bose M, Lambert JD, Ju J, Lu G, Lee MJ, Park S, Husain A and Wang S: Inhibition of intestinal tumorigenesis in Apc (min/+) mice by green tea polyphenols (polyphenol E) and individual catechins. Nutr Cancer 59: 62-69, 2007. (Pubitemid 47549782)
28. Schon MP and Orfanos CE: Transformation of human keratinocytes is characterized by quantitative and qualitative alterations of the T-16 antigen (TROP2, MOv-16). Int J Cancer 60: 88-92, 1995.